News in the Life Sciences Industry

Stockholm, March 12, 2019 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) announces that the company will participate at the Stockholm Corporate Finance 11th Life Science Seminar in Stockholm. The presentation will take place at 9am on Wednesday, March 13, 2019. Dr. Uli Hacksell,... Read more ››

SEOUL, South Korea and UPPSALA, Sweden, 12 March ,2019 /PRNewswire/ -- Dong-A ST Co., Ltd. (170900: Korea SE), the Korean pharmaceutical company, and Beactica AB, the Swedish drug discovery company, today announced an expansion of their research and licensing agreement. The... Read more ››

LUND, Sweden, March 12, 2019 /PRNewswire/ -- BioInvent International AB (OMXS: BINV), a company focusing on the discovery and development of novel and first-in-class immuno-modulatory antibodies to treat cancer, announces today the publication of a review article in Frontiers in Immunology... Read more ››

BRUSSELS, March 11, 2019 /PRNewswire/ -- UCB, a global biopharmaceutical company, announced detailed findings from the investigational study C-AXSPAND, the Phase 3, multi-center, double-blind, placebo-controlled study conducted over 52 weeks, demonstrating positive results for CIMZIA® (certolizumab... Read more ››

STOCKHOLM, March 8, 2019 /PRNewswire/ -- With the number of new cancer cases globally expected to rise by about 70 percent over the next two decades([1-2]), access to radiotherapy - a key treatment modality for up to 60 percent of cancer patients - is more critical than ever. Since the manufacture... Read more ››

STOCKHOLM, March 8, 2019 /PRNewswire/ -- Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced the results of the interim analysis for the company's pivotal phase III study aimed at getting the candidate drug IsoConDa (isoflurane) approved for inhalation sedation in intensive care in... Read more ››

STOCKHOLM, March 8, 2019 /PRNewswire/ -- 91 out of a total of 106 patienter with type 1 diabetes are included in the European phase IIb trial DIAGNODE-2, where the diabetes vaccine Diamyd® is given directly into the lymph node with the aim to preserve the patients' endogenous insulin production.... Read more ››